Combined effect of volumetric breast density and body mass index on breast cancer risk

被引:21
|
作者
Engmann, Natalie J. [1 ]
Scott, Christopher G. [2 ]
Jensen, Matthew R. [2 ]
Winham, Stacey [2 ]
Miglioretti, Diana L. [3 ,4 ]
Ma, Lin [5 ]
Brandt, Kathleen [2 ]
Mahmoudzadeh, Amir [6 ]
Whaley, Dana H. [2 ]
Hruska, Carrie [2 ]
Wu, Fang [2 ]
Norman, Aaron D. [2 ]
Hiatt, Robert A. [7 ]
Heine, John [8 ]
Shepherd, John [9 ]
Pankratz, V. Shane [10 ]
Vachon, Celine M. [2 ]
Kerlikowske, Karla [7 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
[5] Kaiser Permanente Div Res, Oakland, CA USA
[6] Accenture, San Francisco, CA USA
[7] Univ Calif San Francisco, Dept Med & Epidemiol & Biostat, San Francisco, CA 94143 USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[9] Univ Hawaii, Honolulu, HI 96822 USA
[10] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA
基金
美国国家卫生研究院;
关键词
Breast density; Mammographic density; Breast cancer; Body mass index; MAMMOGRAPHIC DENSITY; SUBSEQUENT RISK; WOMENS HEALTH; ASSOCIATION; ADIPOSITY; SIZE; AREAS;
D O I
10.1007/s10549-019-05283-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundBreast density and body mass index (BMI) are used for breast cancer risk stratification. We evaluate whether the positive association between volumetric breast density and breast cancer risk is strengthened with increasing BMI.MethodsThe San Francisco Mammography Registry and Mayo Clinic Rochester identified 781 premenopausal and 1850 postmenopausal women with breast cancer diagnosed between 2007 and 2015 that had a screening digital mammogram at least 6months prior to diagnosis. Up to three controls (N=3535) were matched per case on age, race, date, mammography machine, and state. Volumetric percent density (VPD) and dense volume (DV) were measured with Volpara (TM). Breast cancer risk was assessed with logistic regression stratified by menopause status. Multiplicative interaction tests assessed whether the association of density measures was differential by BMI categories.ResultsThe increased risk of breast cancer associated with VPD was strengthened with higher BMI for both premenopausal (p(interaction)=0.01) and postmenopausal (p(interaction)=0.0003) women. For BMI<25, 25-30, and >= 30kg/m(2), ORs for breast cancer for a 1SD increase in VPD were 1.24, 1.65, and 1.97 for premenopausal, and 1.20, 1.55, and 2.25 for postmenopausal women, respectively. ORs for breast cancer for a 1SD increase in DV were 1.39, 1.33, and 1.51 for premenopausal (p(interaction)=0.58), and 1.31, 1.34, and 1.65 (p(interaction)=0.03) for postmenopausal women for BMI<25, 25-30 and >= 30kg/m(2), respectively.ConclusionsThe effect of volumetric percent density on breast cancer risk is strongest in overweight and obese women. These associations have clinical relevance for informing prevention strategies.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 50 条
  • [21] Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers
    Susann E. Schetter
    Terryl J. Hartman
    Jason Liao
    John P. Richie
    Bogdan Prokopczyk
    Cindy DuBrock
    Carina Signori
    Christopher Hamilton
    Laurence M. Demers
    Karam El-Bayoumy
    Andrea Manni
    Breast Cancer Research and Treatment, 2014, 146 : 355 - 363
  • [22] Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer
    Feigelson, Heather Spencer
    Bodelon, Clara
    Powers, J. David
    Curtis, Rochelle E.
    Buist, Diana S. M.
    Veiga, Lene H. S.
    Bowles, Erin J. Aiello
    de Gonzalez, Amy Berrington
    Gierach, Gretchen L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (09): : 1156 - 1160
  • [23] Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status
    Bissell, Michael C. S.
    Kerlikowske, Karla
    Sprague, Brian L.
    Tice, Jeffery A.
    Gard, Charlotte C.
    Tossas, Katherine Y.
    Rauscher, Garth H.
    Trentham-Dietz, Amy
    Henderson, Louise M.
    Onega, Tracy
    Keegan, Theresa H. M.
    Miglioretti, Diana L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (10) : 2048 - 2056
  • [24] A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk
    Moore, Steven C.
    Playdon, Mary C.
    Sampson, Joshua N.
    Hoover, Robert N.
    Trabert, Britton
    Matthews, Charles E.
    Ziegler, Regina G.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (06): : 588 - 597
  • [25] Body mass index and breast cancer risk in African American women
    Zhu, KM
    Caulfield, J
    Hunter, S
    Roland, CL
    Payne-Wilks, K
    Texter, L
    ANNALS OF EPIDEMIOLOGY, 2005, 15 (02) : 123 - 128
  • [26] Inflammatory breast cancer and body mass index
    Chang, S
    Buzdar, AU
    Hursting, SD
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3731 - 3735
  • [27] Body mass index in breast cancer subtypes
    Petekkaya, I.
    Arslan, C.
    Dogan, E.
    Solak, M.
    Keskin, O.
    Kertmen, N.
    Ozisik, Y. Y.
    Altundag, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Volumetric Breast Density Combined with Masking Risk: Enhanced Characterization of Breast Density from Mammography Images
    Fieselmann, Andreas
    Jerebko, Anna K.
    Mertelmeier, Thomas
    BREAST IMAGING, IWDM 2016, 2016, 9699 : 486 - 492
  • [29] Correction to: Prediction of breast cancer risk by automated volumetric breast density measurement
    Miyako Nara
    Tomoyuki Fujioka
    Mio Mori
    Tomoyuki Aruga
    Ukihide Tateishi
    Japanese Journal of Radiology, 2024, 42 : 435 - 435
  • [30] Association of Daily Alcohol Intake, Volumetric Breast Density, and Breast Cancer Risk
    Rustagi, Alison S.
    Scott, Christopher G.
    Winham, Stacey J.
    Brandt, Kathleen R.
    Norman, Aaron D.
    Jensen, Matthew R.
    Shepherd, John A.
    Hruska, Carrie
    Heine, John J.
    Pankratz, Vernon S.
    Kerlikowske, Karla
    Vachon, Celine M.
    JNCI CANCER SPECTRUM, 2021, 5 (02)